The partnership will focus on cell and gene therapy programs as well as translational research capabilities developed by Boston Children’s.
Under the agreement, Boston Children’s and ElevateBio can form multiple cell and gene therapy companies together, and Boston Children’s researchers will have access to ElevateBio’s technologies and manufacturing capabilities.
ElevateBio also will commit to sponsored research agreements with Boston Children’s investigators as part of the company formation process.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
